Nifty

:

26027.30

Sensex

:

85213.36

-19.65 (-0.08%)
-54.30 (-0.06%)

Login

Nifty
Sensex

:
:

26027.30
85213.36

-19.65 (-0.08%)
-54.30 (-0.06%)

Krebs Biochemicals & Industries Ltd.

Pharmaceuticals & Drugs

Rating :

50/99

BSE: 524518 | NSE: KREBSBIO

Watchlist

NSE BSE

68.66

12-Dec-2025

Open
High
Low
Previous Close

67.5
73.79
67.5
69.39

Volume
Traded Value (lacs)
52 Week High
52 Week Low

24968
1738122.48
113.5
63.6

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

151.61
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

370.92
N/A
-0.96

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

42.10
-4.21
-5.99

EBITDA CAGR (%)

10 Years
5 Years
3 Years

1.94
-3.09
-0.97

PAT CAGR (%)

10 Years
5 Years
3 Years

5.14
-1.02
2.95

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-4.01
-3.40
-1.46

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-25.85
-24.95
-30.45

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 4.17 12.86 -67.57% 5.48 12.89 -57.49% 6.10 11.97 -49.04% 11.47 12.98 -11.63%
Expenses 6.96 15.57 -55.30% 7.57 15.08 -49.80% 11.51 15.09 -23.72% 16.18 15.07 7.37%
EBITDA -2.79 -2.71 - -2.09 -2.20 - -5.41 -3.11 - -4.72 -2.09 -
EBIDTM -67.03% -21.08% -38.08% -17.05% -88.64% -26.01% -41.13% -16.11%
Other Income 0.01 0.09 -88.89% 0.01 0.03 -66.67% 0.34 0.21 61.90% 0.25 0.03 733.33%
Interest 1.73 1.43 20.98% 1.65 1.32 25.00% 1.61 1.27 26.77% 1.56 1.19 31.09%
Depreciation 1.62 1.71 -5.26% 1.60 1.69 -5.33% 1.57 1.67 -5.99% 1.72 1.73 -0.58%
PBT -6.14 -5.76 - -5.32 -5.17 - -8.25 -5.85 - -7.74 -4.98 -
Tax 0.00 0.00 0 0.00 0.00 0 0.02 0.00 0 0.00 0.00 0
PAT -6.14 -5.76 - -5.32 -5.17 - -8.27 -5.85 - -7.74 -4.98 -
PATM -147.42% -44.82% -97.14% -40.12% -135.54% -48.84% -67.49% -38.36%
EPS -2.84 -2.67 - -2.46 -2.39 - -3.83 -2.71 - -3.58 -2.30 -

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 27.22 43.31 50.42 52.13 59.70 53.70 33.41 47.76 33.78 3.53 1.29 Net Sales Growth -46.31% -14.10% -3.28% -12.68% 11.17% 60.73% -30.05% 41.39% 856.94% 173.64% Cost Of Goods Sold 2.17 5.56 6.59 25.68 40.64 25.94 15.86 23.10 12.67 1.20 0.14 Gross Profit 25.05 37.76 43.83 26.46 19.06 27.75 17.55 24.65 21.10 2.33 1.14 GP Margin 92.02% 87.19% 86.93% 50.76% 31.93% 51.68% 52.53% 51.61% 62.46% 66.01% 88.37% Total Expenditure 42.22 58.34 59.15 67.91 93.70 71.28 51.97 57.52 41.28 11.53 13.69 Power & Fuel Cost - 18.52 22.01 14.80 22.23 15.91 10.28 11.70 8.62 0.70 2.87 % Of Sales - 42.76% 43.65% 28.39% 37.24% 29.63% 30.77% 24.50% 25.52% 19.83% 222.48% Employee Cost - 16.30 16.17 15.54 14.96 15.30 14.56 14.41 11.49 5.63 5.67 % Of Sales - 37.64% 32.07% 29.81% 25.06% 28.49% 43.58% 30.17% 34.01% 159.49% 439.53% Manufacturing Exp. - 14.53 11.25 8.48 11.11 10.37 6.77 4.09 4.59 1.07 1.62 % Of Sales - 33.55% 22.31% 16.27% 18.61% 19.31% 20.26% 8.56% 13.59% 30.31% 125.58% General & Admin Exp. - 3.35 3.03 3.25 4.47 3.47 4.05 4.05 3.76 2.88 3.33 % Of Sales - 7.73% 6.01% 6.23% 7.49% 6.46% 12.12% 8.48% 11.13% 81.59% 258.14% Selling & Distn. Exp. - 0.08 0.09 0.16 0.27 0.14 0.16 0.13 0.13 0.05 0.04 % Of Sales - 0.18% 0.18% 0.31% 0.45% 0.26% 0.48% 0.27% 0.38% 1.42% 3.10% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.13 0.29 0.02 0.02 0.01 0.04 % Of Sales - 0% 0% 0% 0% 0.24% 0.87% 0.04% 0.06% 0.28% 1.55% EBITDA -15.01 -15.03 -8.73 -15.78 -34.00 -17.58 -18.56 -9.76 -7.50 -8.00 -12.40 EBITDA Margin -55.14% -34.70% -17.31% -30.27% -56.95% -32.74% -55.55% -20.44% -22.20% -226.63% -961.24% Other Income 0.61 0.71 0.45 0.62 1.16 0.62 0.37 0.33 0.21 0.08 1.03 Interest 6.55 5.91 4.69 2.97 5.39 6.28 6.00 6.29 5.17 3.49 0.74 Depreciation 6.51 6.69 6.77 6.56 6.30 5.12 4.68 4.40 4.15 4.23 4.49 PBT -27.45 -26.92 -19.73 -24.69 -44.53 -28.36 -28.87 -20.12 -16.61 -15.65 -16.60 Tax 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Rate -0.07% -0.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% PAT -27.47 -26.94 -19.73 -24.69 -44.53 -28.36 -28.87 -20.01 -17.82 -16.05 -16.32 PAT before Minority Interest -27.47 -26.94 -19.73 -24.69 -44.53 -28.36 -28.87 -20.01 -17.82 -16.05 -16.32 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -100.92% -62.20% -39.13% -47.36% -74.59% -52.81% -86.41% -41.90% -52.75% -454.67% -1265.12% PAT Growth 0.00% - - - - - - - - - EPS -12.72 -12.47 -9.13 -11.43 -20.62 -13.13 -13.37 -9.26 -8.25 -7.43 -7.56

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds -146.24 -119.22 -99.46 -75.09 -42.73 -25.00 -14.29 -17.78 1.48 13.01 Share Capital 21.56 21.56 21.56 21.56 19.62 18.00 16.63 13.74 13.74 13.06 Total Reserves -167.80 -140.78 -121.02 -96.65 -66.52 -50.65 -30.92 -31.52 -12.27 -3.72 Non-Current Liabilities 211.75 235.56 225.34 186.83 153.76 115.66 101.79 101.37 88.88 73.88 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.89 5.03 21.40 Unsecured Loans 161.25 183.50 173.25 132.93 100.55 65.51 50.23 49.78 37.76 3.91 Long Term Provisions 3.06 3.05 2.60 2.63 2.56 2.46 4.04 3.68 2.82 3.57 Current Liabilities 103.53 61.83 49.10 78.06 48.19 43.13 54.86 42.28 31.72 29.52 Trade Payables 18.15 18.97 15.28 37.91 20.78 22.65 21.44 17.76 10.99 12.37 Other Current Liabilities 33.63 31.87 22.57 29.01 15.92 18.50 32.00 23.27 19.86 16.34 Short Term Borrowings 50.96 9.93 9.99 9.99 10.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 0.79 1.06 1.26 1.17 1.49 1.99 1.43 1.25 0.87 0.82 Total Liabilities 169.04 178.17 174.98 189.80 159.22 133.79 142.36 125.87 122.08 116.41 Net Block 145.70 149.96 147.31 138.71 117.93 105.29 101.27 100.77 102.17 93.10 Gross Block 314.11 312.46 303.04 287.95 260.88 243.11 234.41 229.51 226.55 213.24 Accumulated Depreciation 168.40 162.50 155.73 149.25 142.95 137.82 133.15 128.74 124.38 120.14 Non Current Assets 158.78 160.73 158.92 154.31 137.80 114.94 111.39 108.64 109.10 107.03 Capital Work in Progress 3.09 2.00 4.09 8.38 11.94 4.19 3.48 3.73 3.50 10.54 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 9.98 8.77 7.52 7.23 7.71 5.24 6.22 3.72 3.23 3.19 Other Non Current Assets 0.00 0.00 0.00 0.00 0.23 0.21 0.42 0.41 0.20 0.20 Current Assets 10.26 17.44 16.06 35.49 21.42 18.86 30.98 17.24 12.97 9.39 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 6.03 9.80 11.95 25.56 16.60 15.00 8.96 11.73 5.45 5.64 Sundry Debtors 0.05 1.90 0.53 0.88 0.30 0.20 2.91 0.32 1.59 0.03 Cash & Bank 0.14 0.14 0.09 0.10 0.71 0.17 17.32 0.42 0.12 0.27 Other Current Assets 4.04 0.54 0.65 0.59 3.80 3.49 1.78 4.77 5.81 3.46 Short Term Loans & Adv. 3.39 5.06 2.85 8.36 3.33 3.18 1.57 4.44 5.67 3.38 Net Current Assets -93.27 -44.39 -33.04 -42.57 -26.77 -24.27 -23.88 -25.04 -18.74 -20.14 Total Assets 169.04 178.17 174.98 189.80 159.22 133.80 142.37 125.88 122.07 116.42

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -7.89 2.36 -24.71 -17.22 -14.57 -35.50 3.90 -6.19 -11.20 -15.26 PBT -26.92 -19.73 -24.69 -44.53 -28.36 -28.87 -20.12 -16.61 -16.05 -16.60 Adjustment 12.41 11.88 9.82 11.41 11.68 8.95 10.31 6.46 10.67 3.45 Changes in Working Capital 6.64 10.21 -9.84 15.90 2.11 -15.58 13.71 9.12 -2.33 -1.38 Cash after chg. in Working capital -7.88 2.36 -24.71 -17.22 -14.57 -35.50 3.90 -1.02 -7.71 -14.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -5.17 -3.49 -0.74 Tax Paid -0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.97 -7.82 -12.64 -22.90 -22.55 -10.22 -4.32 -2.77 -4.70 -4.00 Net Fixed Assets -2.74 -7.33 -10.80 -23.51 -25.52 -9.41 -4.65 -3.19 -6.27 -49.48 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -2.23 -0.49 -1.84 0.61 2.97 -0.81 0.33 0.42 1.57 45.48 Cash from Financing Activity 12.86 5.50 37.34 39.51 37.66 28.58 17.32 9.26 15.75 13.22 Net Cash Inflow / Outflow 0.00 0.05 -0.01 -0.61 0.54 -17.14 16.90 0.30 -0.15 -6.04 Opening Cash & Equivalents 0.14 0.09 0.10 0.71 0.17 17.32 0.42 0.12 0.27 6.31 Closing Cash & Equivalent 0.14 0.14 0.09 0.10 0.71 0.17 17.32 0.42 0.12 0.27

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) -67.83 -55.29 -46.13 -34.83 -23.91 -18.14 -8.59 -12.49 1.04 6.91 ROA -15.52% -11.17% -13.54% -25.51% -19.36% -20.91% -14.92% -14.38% -13.46% -14.60% ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -296.70% -683.34% ROCE -29.92% -18.99% -28.59% -57.38% -40.28% -56.96% -35.41% -28.95% -27.13% -25.38% Fixed Asset Turnover 0.14 0.16 0.18 0.22 0.21 0.14 0.21 0.15 0.02 0.01 Receivable days 8.23 8.79 4.91 3.60 1.71 17.00 12.36 10.34 83.55 51.87 Inventory Days 66.69 78.69 131.30 128.88 107.38 130.87 79.07 92.84 573.34 1435.63 Payable days 1219.44 948.90 378.02 263.51 305.42 148.85 123.16 120.44 290.43 338.13 Cash Conversion Cycle -1144.52 -861.42 -241.81 -131.03 -196.34 -0.98 -31.73 -17.27 366.46 1149.37 Total Debt/Equity -1.45 -1.62 -1.84 -1.91 -2.37 -2.03 -3.74 -3.16 32.19 3.27 Interest Cover -3.55 -3.21 -7.30 -7.26 -3.52 -3.81 -2.18 -2.45 -3.60 -21.09

Top Investors:

sun pharmaceutical industries ltd

Annual Reports:

News Update:

Krebs Biochem.&Inds - Quarterly Results
5th Nov 2025, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback